ASPs to drop even as glove demand stays up post-pandemic — AmInvestment Bank
KUALA LUMPUR (Nov 12): AmInvestment Bank believes that while glove demand will stay stable post-Covid-19 pandemic, average selling prices (ASPs) will drop as there will no longer be a rush for gloves. We reckon that ASP will stabilise at a higher level than pre-pandemic level due to the broader usage of gloves,” it said in a note on Top Glove Corp Bhd today.
The research house’s analyst Thong Pak Leng said it believed that glove demand will remain strong, based on reasons outlined by Top Glove during a webinar, which include a higher awareness of personal hygiene and broader use of gloves beyond the healthcare sector. In addition, Thong said there may not be an oversupply of gloves after the pandemic, as Top Glove had pointed out that there are key issues in ramping up supply that need to be addressed, including the availability of contractors to build production lines, the shortage of foreign workers and constraint of nitrile raw material.
Top Glove has also allocated 30% of its capacity for spot orders. “The spot orders for nitrile glove have been fully sold for the next three months. Meanwhile, the spot orders for natural rubber powder-free gloves are also increasing due to the long lead time of nitrile gloves,” said Thong. Presently, Top Glove has a total production capacity of 90 billion pieces per annum.
To expand further, Top Glove has allocated capital expenditure of RM10 billion over the next five years for capacity expansion to double its current capacity by the end of 2025, said Thong. This will be done in stages whereby 14 billion pieces will be added for FY21 and 16 billion for FY22.
AmInvestment Bank maintains its "hold" call on the stock with a lower fair value of RM7.88, adding that the group’s fundamentals remain solid for the next few years.
“We maintain our view that Top Glove’s net profit will peak in FY21 as demand soars from the Covid-19 pandemic with increased capacity expansions. We make no changes to our FY21–FY23 net profit forecasts at RM6.5 billion, RM2.3 billion and RM2.2 billion respectively.
“Our ASP assumptions are US$60 per 1,000 pieces for FY21, US$35 per 1,000 pieces for FY22 and US$28 per 1,000 pieces for FY23 with an average utilisation rate of more than 80%,” said Thong.
Top Glove is currently fourth on Bursa’s top losers list, having fallen 19 sen or 2.42% to RM7.67. The stock is currently valued at RM62.34 billion.
Ya, will pick up again tomorrow. Now in a buying mode. Greedy with everyone is Fearful. Fearful when everyone is Greedy... Let's see when happen next week.. after the Vaccine hype is over...
**** Interesting to know that FLU VACCINE normally lasted about 4 MONTHS. **** Pfizer vaccine (even if able to achieve 90% efficacy) is not a global solution. Even Oxford, Moderna vaccine are proved to be effective will not solve the Covid pandemic for now, only lessen (hopefully).
Covid seemed to have been around for a long time but in fact only about a year or less. There are still many things that scientist do not understand. Whatever that we could out with in such a short time is already a miracle with the hope to bring the Covid under control to acceptable level but will not end it. Heighten hygiene SOP will be place for a long long time just like heighten airport security after the 9/11 incident.
Buy again tomorrow. Looks like Covid is increasing like crap this coming winter. 144 k in the US yesterday. I love losses too. What can I do except to buy on a dip. I hope it will drop so I can buy and makes more money when it blow up.
The day Pfizer announced and claimed the success of the vaccine for Covid-19, the CEO sold a bulk of his shares in Pfizer. Don't you think this is a bit strange?
No joy for glove stocks... most penny and speculative stocks went up. Tomorrow it's oil and gas stocks. Get ready for the big bucks. Forget about glove stocks.
When the Dow fall, asian market will follow suit. Vaccine news fail to take off the US market. Glove still in play strongly due to uncontrolled pandemic. HAPPY HUNTING.
US and Europe have pared gains on vaccine euphoria. Back to COVID safe stocks like Tech. Mercator Poland gloves was up 6% yesterday. Pzifer CEO sold 60% of his stocks the day he announced their vaccine efficacy rates, don't you think if he was so confident on the imminent vaccine roll-out he would have kept his stocks longer? Watch this space.
Good Morning folks... It's another day of buying on a dip. What a great opportunity to add. Going 80% in on gloves stocks. Next 2 weeks... Boom... after all the Vaccine hype is over, Covid increasing and IB find out banks are boring.
Liquidity... Yep. Nothing will change with Banks Fundamentals for the next 6-12 months. Vaccine hype and sector rotation. All will come back to gloves after QR. Good time to add. Will add more today...might be a last opportunity as the beaten gloves stocks look like it is going to Blow.
Dr. Michael Osterholm -- an adviser to President-elect Joe Biden – this week floated the idea of a four- to six-week lockdown as the nation is approaching what he called "COVID hell," but later clarified that he had not made this recommendation to the Biden team.
New IPO: Building management systems (BMS), solar thermal systems and energy-saving services provider, Solar District Cooling Bhd aims to list on the Ace Market!
MQ Trader 535 views | 3 d ago
0:17
New IPO: The onshore and offshore support services provider for the O&G industry, Steel Hawk Bhd aims to list on the Ace Market!
MQ Trader 12777 views | 11 d ago
0:17
New IPO: The largest mini-market player and a leading groceries retailer in Malaysia, 99 Speed Mart Retail Holdings Bhd aims to list on the Main Market!
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
SimonJB
377 posts
Posted by SimonJB > 2020-11-12 15:15 | Report Abuse
strong support at 4.00 - 4.05